Preview: Aardvark Therapeutics, Inc Set To IPO Tomorrow

Aardvark Therapeutics, Inc AARD IPO will take place February, 13 on the NASDAQ exchange under the ticker AARD.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on August 12, 2025.

See also: Benzinga IPO Calendar

About Aardvark Therapeutics, Inc

Aardvark Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.